The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Maduro Faces Rare Narcoterrorism Charges in U.S. Court
Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Anthropic Sues Pentagon Over AI Blacklist, Citing Free Speech Violations
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push
Dollar Strengthens as U.S.-Iran Peace Talks Send Mixed Signals
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
xAI Faces Federal Lawsuit Over Grok AI-Generated Child Sexual Abuse Material
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
Wall Street Slides as Iran War Uncertainty, Oil Surge, and AI Fears Rattle Markets
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence
Costco Faces Class Action Lawsuit Over Tariff Refunds as Supreme Court Strikes Down Trump's IEEPA Tariffs
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
Gold Prices Surge on U.S.-Iran Ceasefire Reports 



